Baseline glucocorticoids are drivers of body mass gain in a diving seabird by Hennin, Holly L. et al.
University of Windsor 
Scholarship at UWindsor 
Biological Sciences Publications Department of Biological Sciences 
2016 
Baseline glucocorticoids are drivers of body mass gain in a diving 
seabird 
Holly L. Hennin 
University of Windsor 
Alicia M. Wells-Berlin 
University of Windsor 
Oliver P. Love 
University of Windsor 
Follow this and additional works at: https://scholar.uwindsor.ca/biologypub 
 Part of the Biology Commons 
Recommended Citation 
Hennin, Holly L.; Wells-Berlin, Alicia M.; and Love, Oliver P., "Baseline glucocorticoids are drivers of body 
mass gain in a diving seabird" (2016). Ecology and Evolution, 6, 6, 1702-1711. 
https://scholar.uwindsor.ca/biologypub/1043 
This Article is brought to you for free and open access by the Department of Biological Sciences at Scholarship at 
UWindsor. It has been accepted for inclusion in Biological Sciences Publications by an authorized administrator of 
Scholarship at UWindsor. For more information, please contact scholarship@uwindsor.ca. 
Baseline glucocorticoids are drivers of body mass gain in a
diving seabird
Holly L. Hennin1, Alicia M. Wells-Berlin2 & Oliver P. Love1
1Department of Biological Sciences and Great Lakes Institute for Environmental Research (GLIER), University of Windsor, Windsor, Ontario, Canada
2U.S. Geological Survey, Patuxent Wildlife Research Center, Laurel, Maryland
Keywords
Baseline corticosterone, body mass, captive
study, manipulation, white-winged scoter.
Correspondence
Holly L. Hennin, Department of Biological
Sciences and Great Lakes Institute for
Environmental Research (GLIER), University of
Windsor, Windsor, Ontario, Canada.
Tel: 519-253-3000 x2701;
Fax: 519-971-3609;
E-mail: hennin@uwindsor.ca
Funding Information
This research was supported by the Natural
Sciences Engineering and Research Council
of Canada [Grant # 478021-2015] and the
Canada Research Chairs Program.
Received: 11 November 2015; Revised: 11
January 2016; Accepted: 18 January 2016
Ecology and Evolution 2016; 6(6):
1702–1711
doi: 10.1002/ece3.1999
Abstract
Life-history trade-offs are influenced by variation in individual state, with
individuals in better condition often completing life-history stages with greater
success. Although resource accrual significantly impacts key life-history deci-
sions such as the timing of reproduction, little is known about the underlying
mechanisms driving resource accumulation. Baseline corticosterone (CORT, the
primary avian glucocorticoid) mediates daily and seasonal energetics, responds
to changes in food availability, and has been linked to foraging behavior,
making it a strong potential driver of individual variation in resource accrual
and deposition. Working with a captive colony of white-winged scoters (Mela-
nitta fusca deglandi), we aimed to causally determine whether variation in base-
line CORT drives individual body mass gains mediated through fattening rate
(plasma triglycerides corrected for body mass). We implanted individuals with
each of three treatment pellets to elevate CORT within a baseline range in a
randomized order: control, low dose of CORT, high dose of CORT, then blood
sampled and recorded body mass over a two-week period to track changes in
baseline CORT, body mass, and fattening rates. The high CORT treatment sig-
nificantly elevated levels of plasma hormone for a short period of time within
the biologically relevant, baseline range for this species, but importantly did not
inhibit the function of the HPA (hypothalamic–pituitary–adrenal) axis. Further-
more, an elevation in baseline CORT resulted in a consistent increase in body
mass throughout the trial period compared to controls. This is some of the first
empirical evidence demonstrating that elevations of baseline CORT within a
biologically relevant range have a causal, direct, and positive influence on
changes in body mass.
Introduction
Variation in individual state (e.g., body condition/ener-
getic stores) is the source of numerous life-history trade-
offs (Stearns 1992) and can act as both a constraint, and
a driver, of fitness-related life-history decisions
(McNamara and Houston 1996). During energetically
demanding life-history stages (i.e., migration, reproduc-
tion), individuals with greater energetic stores (i.e., higher
body condition) are predicted to complete these stages
with greater success (Stearns 1992; Rowe et al. 1994;
McNamara and Houston 1996; Kisdi et al. 1998). For
example, individuals with higher body mass are often able
to arrive earlier on the breeding grounds and reproduce
earlier and with greater success (Lepage et al. 2000; Be^ty
et al. 2003; Gladbach et al. 2010; Descamps et al. 2011).
Although individual variation in the rate at which accu-
mulating these energetic stores (i.e., lipids) is theorized to
have a major impact on reproductive timing and invest-
ment (Be^ty et al. 2003; McNamara and Houston 2008),
there is scant empirical data on the underlying mecha-
nisms driving the procurement and accumulation of
endogenous resources (Hennin et al. 2015).
Baseline glucocorticoids (GCs – corticosterone/cortisol)
are hormones found in all vertebrates that mediate varia-
tion in energetic demand (Dallman et al. 1993; Landys
et al. 2006). As such, baseline GCs experience daily and
seasonal variation, with higher levels being associated with
more energetically demanding life-history stages (Romero
2002; Landys et al. 2006; Crespi et al. 2013). Baseline GCs
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are elevated when resources are scarce or individuals are
in a negative energetic state (Love et al. 2005; Kitaysky
et al. 2007; Jenni-Eiermann et al. 2008), presumably to
stimulate foraging behavior and subsequent resource
acquisition (L~ohmus et al. 2006; Crossin et al. 2012). In
individuals preparing for energetically demanding life-his-
tory stages, elevated baseline GCs within biologically rele-
vant levels result in higher foraging rates (Astheimer et al.
1992; Kitaysky et al. 1999; L~ohmus et al. 2006; Angelier
et al. 2007; Crossin et al. 2012), increased rates of condi-
tion gain (Crossin et al. 2012), and larger lipid stores
(Holberton 1999; Holberton et al. 2007), all of which can
positively influence fitness (Crossin et al. 2012). Nonethe-
less, it is important to remember the dual nature of ele-
vated GCs (L~ohmus et al. 2006), especially when
manipulating them in wild organisms (Crossin et al.
2015). When GCs are experimentally elevated outside the
baseline range – such as during an acute stress response
or via pharmacological manipulation, for example – they
promote the expenditure of lipid stores to fuel survival-
related behaviors (Wingfield et al. 1998; Breuner and
Hahn 2003), thereby resulting in a negative proximate
impact on body condition (Criscuolo et al. 2005; Bour-
geon and Raclot 2006; Jenni-Eiermann et al. 2008; Ange-
lier et al. 2009, 2010). As such, while lower, biologically
relevant elevations of GCs in a baseline range are expected
to have positive impacts on individual state (Crossin et al.
2015; Hennin et al. 2015), greater elevations are expected
to induce an emergency life-history stage or stress
response, and have a short-term negative impact on indi-
vidual state (Wingfield et al. 1998).
We manipulated baseline corticosterone (CORT, the
primary avian GC) in a captive colony of white-winged
scoters (Melanitta fusca deglandi), a northern breeding,
diving seaduck. Our overall goal was to examine whether
variation in baseline GCs acts as a causal mechanism for
positive impacts on individual state in a species that gains
lipid stores prior to migration and commencing breeding.
Our specific aims were to (1) examine whether a biologi-
cally relevant exogenous increase of CORT within a base-
line range resulted in positive changes in body mass (i.e.,
increases in body fat), (2) determine whether this effect
was due to either positive effects of elevated baseline
CORT (i.e., via predicted increases in resource acquisi-
tion) or the often presumed “inhibitory” effects of ele-
vated baseline CORT (i.e., via negative feedback through
the hypothalamic–pituitary–adrenal (HPA) axis), and (3)
determine whether increases in body mass were reflected
by an increase in plasma triglycerides (a measure of phys-
iological fattening rate). For the latter, we focused on
plasma triglycerides (TRIG) as they are a measure of the
lipids synthesized by the liver used for depositing fat
stores endogenously (Jenni and Schwilch 2001; Cerasale
and Guglielmo 2006; Zajac et al. 2006; Anteau and Afton
2008) and when corrected for body mass, indicate an
individual’s physiological fattening rate (Williams et al.
2007).
Materials and Methods
Study site and colony
Work was conducted between January and April 2013
using a captive colony of adult white-winged scoters
(hereafter scoters; male: n = 5; female: n = 8) housed at
the PWRC (Patuxent Wildlife Research Center) in Laurel,
MD, USA. Birds were kept in mixed-sex, outdoor pens
covered with shade cloth. Pens were 11.5 m2 with gravel
substrate and a conical pond (2.1 m diameter, ~1 m deep
at center) with continual flowing freshwater. Experimental
pens were separated from each other by at least two non-
experimental pens to reduce researcher influences on GCs
and bird behavior. Birds were maintained on an ad libitum
diet of Mazuri seaduck diet pellets (PMI Nutrition
International) to ensure that no variation in body mass
or fattening rates could be attributable to differences in
diet composition (Seaman et al. 2005; Cerasale and
Guglielmo 2006). All maintenance and experimental
procedures were approved through both the PWRC
(ACUC approval for “Corticosterone, energetics and
individual state in diving seaducks”) and University of
Windsor (AUPP #12-15: “Mechanisms behind variation
in individual state in diving seaducks) animal care and
use committees.
Experimental design, blood sampling, and
corticosterone manipulation
Three separate 21-day trials were performed. Individuals
were assigned a randomized implantation schedule via
random number generator across trials for each of our
three treatment pellets (Innovative Research of America,
Sarasota, FL) for a repeated-measures design: control pel-
let (15 mg containing cholesterol), a low dose of CORT
(“low CORT”; 15 mg pellet of CORT in a cholesterol
matrix), and a high dose of CORT (“high CORT”; 35 mg
pellet of CORT in a cholesterol matrix). The experimental
manipulation was designed to elevate corticosterone levels
within a biologically relevant baseline range (wild white-
winged scoters: 6.64  1.19 ng mL1; range 0.51–
46.7 ng mL1; Palm et al. 2013), and not to elevate levels
to those seen during an acute stress response. Indeed, we
found that the plasma levels of our manipulated birds fell
well within this baseline range (range 1.00–33.4 ng mL1;
see Results). Although pellets are designed to last 21 days
in mammals, based on previous studies in birds, we
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expected them to last approximately 14 days or less given
their higher basal body temperature (see Bonier et al.
2007; M€uller et al. 2009a,b). We therefore sampled
individuals every 3 days for a total of 14 days (with the
exception of day 5 of the experiment; see ACTH
Challenge details). Birds were given a week of rest before
initiating the next trial.
Blood sampling took place between 0800 h and 1200 h
to control for any potential diel variation in baseline cor-
ticosterone. Individuals in a pen were sampled together
within 3 min of researchers being in sight of the pens to
obtain conservative baseline samples (Romero and Reed
2002) and then weighed (g). Blood samples were collected
by puncturing the tarsal vein using a 26-G needle and
75-lL heparinized capillary tubes. Blood samples were
placed in heparinized storage tubes and centrifuged at
2000 g for 10 min. Plasma was separated from the red
blood cells and stored separately at 80°C until further
analysis. Tarsus measurements (mm) were taken on the
first day of sampling.
On the first day of an experimental trial, birds were
implanted with treatment pellets at the base of the thigh
in an area of lose skin. The leg in which birds were
implanted alternated after each trial. After sanitizing the
implant area with Betadine, the implant site was anes-
thetized locally with 0.36 mg kg1 dose of 5 mg mL1
bupivacaine (Hopsira, Montreal, QC, Canada) using a 25-
G needle. After the local anesthetic had taken effect
(approx. 5 min) and the area was re-sterilized with Beta-
dine, a small incision slightly larger than the pellet was
made in the skin using a #15 scalpel blade, and a pocket
in the subcutis was made for the pellet by gently separat-
ing the skin from the muscle. After the appropriate treat-
ment pellet was inserted under the skin, the wound was
closed using 2–3 sutures of UV degradable monofilament
(PDS* II (polydioxanone) suture; Ethicon, Markham,
ON, Canada). The surgical area was re-sanitized, and the
bird was released back into its pen. The surgical site was
monitored throughout the trial to ensure that it was heal-
ing properly and that there was no infection. In seven
instances (five individuals in trial 2 and 3 in trial 3), indi-
viduals rejected the implanted pellets, encapsulating and
extruding the pellets. As a result, the dosage of CORT to
the individual was ambiguous and unstandardized. There-
fore, the data from those individuals within that trial
were excluded.
Adrenocorticotropic hormone (ACTH)
challenge
On the fourth and fifth days of the experiment for each
trial, birds underwent an ACTH hormonal challenge to
test the responsiveness of the HPA axis (Noirault et al.
1999; Faure et al. 2003; Nilsson et al. 2008). Following a
blood sample to assess baseline CORT, birds were injected
with either 100 IU kg1 of porcine ACTH (Sigma, St.
Louis, MO, USA) dissolved in 0.5 mL of lactated Ringers
solution (Sigma) (high CORT: n = 4, control CORT:
n = 5), or 0.5 mL of lactated Ringers solution (hereafter
referred to as “saline”) as a control (high CORT: n = 4,
control CORT: n = 3) into the breast muscle using a 25-
G needle-equipped syringe. Birds received either ACTH
or saline solution on day 4 and the opposite injection on
day 5 to also obtain individual variation in responses to
the injections. Birds were then placed in individual carrier
crates in a darkened, outdoor area, and blood was sam-
pled 30 and 60 min postinjection before being released
back into their pens. Blood samples were centrifuged at
10,000 rpm for 10 min, and the plasma and red blood
cells were stored separately at 80°C until further analy-
sis.
Physiological assays
Baseline corticosterone (CORT) was measured using a
commercially available, enzyme immunoassay kit based
on competitive binding and previously validated in diving
seaducks (EIA; Assay Designs, Ann Arbor, MI) (Hennin
et al. 2015) and was optimized for white-winged scoters
(Palm et al. 2013). Samples were un-extracted and run in
triplicate at a 1:40 dilution with a 1.5% steroid displace-
ment buffer. Each plate included a CORT-spiked control
sample and a standard curve produced by serially diluting
a kit-provided, 200,000 pg mL1 CORT standard, and
plates were read at 405 nM wavelength (for details see
Hennin et al. 2015). The inter- and intra-assay coefficient
of variation across all plates was 2.66% and 7.78%,
respectively.
Plasma triglycerides (TRIG) were measured using a
commercially available kit (Sigma-Aldrich, Oakville, ON,
Canada) previously validated in diving seaducks (Hennin
et al. 2015). We used a 1:2 dilution for samples before
adding them to a 96-well microplate in duplicate. Each
plate included a serially diluted standard curve of glycerol
standard (2.54 mmol L1) and a control of laying hen
plasma (Sigma-Aldrich Canada, Oakville, ON, Canada).
Reagent A was first added to measure free glycerol, fol-
lowed by Reagent B to measure total glycerol. After the
addition of each reagent, the plates were left to shake for
10 min at 37°C and then read using a plate reader at
540 nM wavelength. The amount of triglycerides
(mmol L1) was calculated by subtracting the amount of
free glycerol found in the first plate read from the
amount of total glycerol found in the second plate read.
Inter- and intra-assay coefficients of variation were 7.61%
and 8.32% for total TRIG, and 7.27% and 4.68% for free
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glycerol, respectively. Final TRIG values were corrected
for body mass to obtain residuals, indicating fattening
rates (Williams et al. 2007).
Statistical analyses
We tested for differences in baseline CORT and size-cor-
rected body mass between treatments and between sexes
at the start of the overall experiment (beginning of trial
1) using an ANOVA (analysis of variance). To test for
trial-induced changes in baseline CORT and potential sea-
sonal effects, we ran an ANOVA with trial number as an
independent variable to test for differences across trials in
baseline CORT. Due to lower than expected blood sample
numbers, in this analysis, we were only able to include
one of an individual’s measures from each of the three
trials (no repeated measures) while maintaining balanced
sample sizes across trials. Data points used in the analyses
were selected randomly using a random number genera-
tor. Data from all trials were included in the analysis as
the influence of CORT pellets within a focal trial did not
influence baseline CORT values in subsequent trials (see
Results). We ran a general linear mixed-effects model
with individual as a random effect to test for trial-
induced changes in size-corrected body mass at the start
of each trial (comparing day 1 measures for all three tri-
als). Size-corrected body masses appeared to demonstrate
a trend toward increasing in the second and third trials
compared to the first trial (trial: F2,8.48 = 3.78, P < 0.06;
trial 1: 1152.1  42.8 g, n = 9, trial 2: 1213.0  42.5 g,
n = 8, trial 3: 1216.2  44.0 g, n = 6). We therefore
suspected that the washout period between trials was too
short, potentially biasing the treatment’s apparent impact
on body mass in subsequent trials. As such, to be as con-
servative as possible, we excluded trials 2 and 3 from
analyses involving body mass and fattening to prevent
any potential biases.
The peak concentration of plasma CORT due to the
treatment pellets was predicted to be approximately
4 days postimplantation (M€uller et al. 2009a). To test
whether the low CORT and high CORT treatments ele-
vated baseline CORT differentially compared to the con-
trol group, we ran two-one-tailed t-tests comparing the
control to each treatment group separately on day 4. The
low CORT treatment did not significantly differ from the
control group on day 4 (t = 0.73, df = 5.78, P < 0.25,
control: n = 4; low CORT: n = 4; Fig. 1A), indicating it
was unsuccessful in elevating CORT. Further, we found
only a moderate effect size (Cohen’s d = 0.52,
r = 0.25). We therefore excluded the low CORT group
from all subsequent analyses as we were aimed to test the
influence of baseline elevations of CORT on changes in
mass. We performed a general linear mixed-model analy-
sis to examine the responsiveness of the HPA axis to the
ACTH challenge, with individual included as a random
effect. We also included the fixed effects of treatment
group, sampling time (initial baseline sample, 30/60 min
postinjection), ACTH treatment, and an interaction
between ACTH treatment and sampling time (with a
Tukey’s post hoc test). We found no effect of sex on dif-
ferences in response to the ACTH trials (F1,7.85 = 0.35,
P = 0.57) and therefore pooled sexes for ACTH trial
analysis.
The change in body mass was calculated as the differ-
ence between the body mass on a given experimental day
and that at the start of the trial, making the comparison
of the relative changes across individuals and sexes possi-
ble. Change in body mass was analyzed using a mixed-
effects generalized linear model including individual as a
random effect, and as fixed effects CORT treatment
group, experimental day, sex, and the interaction between
CORT treatment and experimental day. We ran a Tukey’s
Figure 1. Influence of treatment (exogenous baseline CORT elevation
vs. control) (A) and ACTH injection (B) on baseline levels of
corticosterone in captive white-winged scoters. Data included in
analyses are presented as the model-corrected least square means
and standard errors. Values presented for CORT are back-transformed
from a log transformation. Asterisk indicates a significant difference
between the high CORT group and control group only. Refer to
Table S1 for sample sizes (A).
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post hoc test to test for differences between groups in the
interactive effect. Changes in physiological fattening rate
(TRIG) were analyzed using a general linear model
including experimental day and treatment group as inde-
pendent variables. As it is likely that impacts of elevated
baseline CORT on plasma TRIG are temporally delayed
after foraging, we ran two models: one to compare day 1
one and 4 (expected day of peak CORT secretion) and a
second to compare days 1 and 7 (next sampling day after
peak secretion). We included only one of an individual’s
measures across trials to maintain balanced sample sizes
across trials. Due to low sample sizes, we were unable to
include sex as a variable in fattening rate analyses. Base-
line CORT values were log-transformed for normality in
analyses and back-transformed for figures and to report
means and standard errors. All data met the assumptions
for a parametric test. All analyses were run using JMP
10.0 (SAS Institute, Cary, CA). Results are presented as
means  SEM unless otherwise stated.
Results
Changes in baseline CORT and HPA axis
activity
There were no differences between the three treatment
groups (P > 0.77; Fig. 1A) or between sexes (P > 0.59) in
their initial baseline CORT values at the start of the overall
experiment (F2,6 = 0.23, P > 0.80, n = 9), and no differ-
ences in baseline CORT on the first day of each trial
(F2,9 = 0.42, P > 0.66, n = 9; trial 1: 4.72  1.44 ng mL1,
n = 6; trial 2: 2.90  1.55 ng mL1, n = 4; trial 3:
4.95  1.87 ng mL1, n = 2). However, baseline CORT
was significantly elevated in the high CORT treatment
group compared to control birds by day 4 of the experi-
ment (F2,7 = 12.66, P < 0.005, n = 10 (control = 6, high
CORT = 4); Fig. 1A; Table S1), with a relatively large effect
size (Cohen’s d = 2.14, r = 0.73). Further, males had
higher baseline CORT levels than females (males:
13.48  1.28 ng mL1, n = 5; females: 4.82  1.31
ng mL1, n = 5; P < 0.03). As predicted, individuals
administered ACTH had significantly higher CORT levels
30 and 60 min postinjection compared with saline injec-
tions (sampling time-ACTH treatment interaction: Table 1,
2; Fig. 1B). However, both treatment groups responded to
the ACTH challenge similarly (Table 1; Fig. 1B), indicating
that the exogenous CORT treatment had no significant
effect on the responsiveness of the HPA axis.
Change in body mass and fattening rate
We found no difference in size-corrected body mass
between experimental groups at the beginning of the first
trial (t = 0.10, df = 6.81, P = 0.93, n = 11; control:
0.15  1.18, n = 6; treatment: 0.37  1.92, n = 5). How-
ever, we detected a significant two-way interaction
between treatment and experimental day on the change in
body mass where individuals in the high CORT (n = 5)
treatment had larger positive changes in body mass com-
pared to control (n = 5) individuals (Tables 1, 2;
Fig. 2A). Surprisingly, we did not detect a treatment effect
on physiological fattening rates (TRIG corrected for body
mass) between control and high CORT groups when
comparing either day 1 to day 4 (control: n = 3; high
CORT: n = 4; Tables 1, 2, S1; Fig. 2B) or day 1 to day 7
(control: n = 3; high CORT: n = 3; Tables 1, 2, S1;
Fig. 2B).
Discussion
We successfully experimentally elevated baseline corticos-
terone (CORT) in captive white-winged scoters within a
biologically relevant, baseline range without inhibiting the
activity of the HPA axis. Although we only produced an
ephemeral increase in baseline CORT, peaking on experi-
mental day 4 with levels appearing to return to baseline
levels between day 7 and day 10, individuals demon-
strated a consistent and continual increase in body mass
over the two-week period of implantation. As such, we
have discovered a direct and positive causal relationship
between elevated baseline CORT and increases in body
mass in a diving seaduck. Importantly, this baseline
CORT-mediated increase in body mass was due to a posi-
tive effect of elevated baseline CORT (i.e., likely via pre-
dicted increases in resource acquisition) and not an
“inhibitory” effect of elevated exogenous baseline CORT
Table 1. Summary of fixed effects for ACTH trials, change in body
mass, and fattening rate (plasma TRIG) analyses in response to an
exogenous elevation of baseline corticosterone in captive white-
winged scoters. Bolded values indicate significant effects.
Analysis Variable F df P
ACTH Trial CORT Treatment 0.3 1, 40.58 0.59
ACTH Treatment 4.84 1, 38.41 0.03
Sample Time 28.7 2, 30.83 0.0001
Sample Time*ACTH
Treatment
8.88 2, 30.83 0.0009
Change in
body mass
Experiment Day 8.68 4, 21.35 0.0003
Treatment 60.17 1, 3.43 0.0003
Sex 1.15 1, 3.42 0.35
Experiment
Day*Treatment
4.02 4, 21.35 0.01
Fattening
rate 1–4
Experiment Day 2.69 1 0.18
Treatment 0.21 1 0.67
Fattening
rate 1–7
Experiment Day 1.11 1 0.37
Treatment 3.89 1 0.14
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resulting in negative feedback of the HPA axis. Nonethe-
less, this treatment-related change in body mass was not
mirrored by an increase in the physiological fattening
rate.
Corticosterone secretion dynamics
Only the high CORT treatment pellets significantly ele-
vated CORT in our captive white-winged scoters,
although these levels were well within the expected natu-
ral baseline range for this species in the wild
(6.64  1.19 ng mL1; range 0.51–46.7 ng mL1) (Palm
et al. 2013), indicating that our detected levels were
within a biologically relevant, baseline range. We found
that male white-winged scoters had higher baseline
plasma CORT than females at the peak of CORT release
from the pellet. Pellets implanted in individuals were con-
sistent in size and thus slightly variable across individuals.
It is likely that males, which are larger on average than
females, had a slightly higher metabolic rate than females,
given the inherent positive relationship between body
mass and metabolic rate (e.g., Nagy 2005). As such, if
males had a higher metabolic rate, and individuals were
administered an un-scaled dosage of CORT, males may
have metabolized the pellets more quickly, thereby expos-
ing themselves to greater concentrations of CORT from
the pellets than females. Although the pellets are manu-
factured to elevate CORT over a period of 21 days in
mammals, we found a peak in CORT secretion 3 days
postimplantation (i.e., on experimental day 4) with a
rapid tapering off of CORT beginning approximately one
week postimplantation. Studies in other avian species
using this manipulation technique have found similar
secretion trends in which there is a peak in plasma CORT
concentrations shortly after implantation (1–3 days;
M€uller et al. 2009a) which slowly tapers off until return-
ing to baseline levels (within approximately 7 days
postimplantation; Bourgeon and Raclot 2006; Bonier
et al. 2007; Almasi et al. 2008; M€uller et al. 2009b).
There are three potential reasons for the rapid tapering
off of CORT in these secretion profiles. First, it is possible
that individuals were preventing the release of CORT
either through encapsulation of the pellet or through
clearing CORT from the circulatory system. We moni-
tored the implantation site throughout each experimental
trial to ensure the site was healing and for the presence of
the pellets. Any individuals that had encapsulated pellets
during the trial were removed from analyses due to the
ambiguity in the nature of CORT secretion from the pel-
lets while encapsulated. Second, through negative feed-
back individuals could have begun down-regulating the
endogenous production of CORT due to the rapid influx
Table 2. Parameter estimates for ACTH trial, change in body mass, and fattening rates (mass-corrected plasma TRIG) between experimental day
1 to day 4 and day 1 to day 7 for white-winged scoters. Bolded values indicate significant effects.
Analysis Parameter Estimate SE df t P
ACTH Trial Intercept 1.22 0.08 7.21 15.99 0.0001
CORT Treatment (Control) 0.03 0.05 40.58 0.55 0.59
ACTH Treatment (ACTH) 0.09 0.04 38.41 2.2 0.03
Sample Time (T0) 0.37 0.05 30.83 7.53 0.0001
Sample Time (T30) 0.15 0.05 30.83 3.04 0.005
Sample Time (T0)*ACTH Treatment (ACTH) 0.21 0.05 30.83 4.21 0.0002
Sample Time (T30)*ACTH Treatment (ACTH) 0.1 0.05 30.83 2.01 0.05
Change in body mass Intercept 32.15 3.75 3.35 8.56 0.002
Experiment Day 1 31.10 7.18 21.21 4.33 0.0003
Experiment Day 4 12.80 7.18 21.21 1.78 0.09
Experiment Day 7 1.41 7.49 21.93 0.19 0.85
Experiment Day 10 16.84 7.18 21.21 2.34 0.03
Treatment (Control) 28.43 3.67 3.43 7.76 0.003
Sex (Female) 3.93 3.67 3.43 1.07 0.35
Experiment Day 1*Treatment (Control) 28.17 7.18 21/21 3.92 0.0008
Experiment Day 4*Treatment (Control) 1.53 7.18 21.21 0.21 0.83
Experiment Day 7*Treatment (Control) 9.48 7.49 21.93 1.27 0.22
Experiment Day 10*Treatment (Control) 6.56 7.18 21.21 0.91 0.37
Fattening Day 1–4 Intercept 0.45 0.12 NA 3.83 0.02
Experiment Day 1 0.19 0.12 NA 1.64 0.18
Treatment (Control) 0.05 0.12 NA 0.46 0.67
Fattening Day 1–7 Intercept 0.15 0.16 NA 0.92 0.43
Experiment Day 1 0.18 0.17 NA 1.05 0.37
Treatment (Control) 0.34 0.17 NA 1.97 0.14
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of exogenous CORT (Goutte et al. 2011). To test for this
impact, we intentionally timed our ACTH trials to closely
match the expected maximal secretion of CORT from the
pellets to examine whether the HPA axis was still active
and fully responsive. If the exogenous CORT was inhibit-
ing the HPA axis, then the high CORT birds should have
exhibited a significant depression in endogenous CORT
secretion in response to the ACTH challenge. However,
high CORT birds challenged with ACTH showed CORT
responses that were not significantly different from those
of ACTH-injected control birds. This indicates that the
HPA axis of high CORT birds was still active and able to
secrete endogenous CORT normally. The final and most
likely explanation for the relatively ephemeral nature of
the CORT pellets is that they are primarily designed for
use in mammals, and therefore, pellets were likely metab-
olized more quickly in avian species which exhibit higher
relative metabolic rates (M€uller et al. 2009a). Again, this
assumption is supported by recent work using these pel-
lets in a number of avian species (Bourgeon and Raclot
2006; Bonier et al. 2007; Almasi et al. 2008; M€uller et al.
2009b).
Linking elevated baseline corticosterone to
changes in body mass
We found that individuals with exogenously elevated
baseline CORT increased in body mass throughout the
trial period. Although a number of studies have examined
relationships between elevated baseline CORT and forag-
ing behaviors (Astheimer et al. 1992; Dallman et al. 1993;
Breuner et al. 1998), here we confirm that this CORT-
mediated effect on body mass was due to a direct positive
effect of elevated baseline CORT, presumably via the pre-
viously observed increase in resource acquisition. It is key
to note that we witnessed changes in mass in the high
CORT birds, particularly later in the trial period, and no
changes occurred in our control birds across the trial,
indicating that these results were not due to seasonal
influences but rather due to the treatment. Importantly,
CORT-mediated increases in body mass did not occur as
a result of the elevated exogenous baseline CORT inhibit-
ing the HPA axis, thereby reducing endogenous produc-
tion of CORT with an associated downstream positive
impact on body mass. Rather, individuals responded
directly to the elevation of baseline CORT itself, with sub-
sequent increases in body mass. It is well known that rela-
tionships between elevated baseline CORT and changes in
body mass depend heavily on the interactions between
life-history stage, life-history strategy, and the dosage of
CORT administered in a given species (Crossin et al.
2015). For instance, yellow-rumped warblers (Setophaga
coronata) exposed to longer day lengths (i.e., simulating
spring migration) exhibited elevated baseline CORT secre-
tion with a temporally paired increase in body mass (Hol-
berton 1999). Similarly, an experimental reduction in
baseline CORT levels in dark-eyed juncos (Junco hye-
malis) resulted in less body mass gain than individuals
with higher, normal baseline levels (Holberton et al.
2007). Finally, in wild macaroni penguins (Eudyptes
chrysolophus), individuals with experimentally elevated
baseline CORT exhibited increased foraging behavior and
higher body mass gain (Crossin et al. 2012). Conversely,
incubating common eiders (Somateria mollissima) with
experimentally elevated CORT outside the normal base-
line range (i.e., into the range of an acute stress response)
lost significant amounts of body mass (Bourgeon and
Raclot 2006), underscoring the dual nature of CORT
secretion (Landys et al. 2006) and that the direction of
this relationship is highly context dependent (Crossin
et al. 2015). Although our results indicate that CORT acts
as a “direct” mechanism driving an increase in body
mass, CORT can also influence or be influenced by the
secretion of other hormones (e.g., ghrelin, thyroid hor-
mone, insulin) or neuropeptides (e.g., neuropeptide Y)
which can have downstream consequences for foraging
Figure 2. The impact of an exogenous elevation in baseline CORT on
changes in body mass (A) and fattening rate (B) in captive white-
winged scoters across experimental days. Data included in analyses
are presented as the model-corrected least square means and
standard errors. Letters indicate significant differences between
groups. Refer to Table S1 for sample sizes (B).
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(Landys et al. 2006; Cornelius et al. 2013). As such,
CORT may be a component of a complex set of mecha-
nisms which can influence body mass, the strength of
which may be dependent on life-history stage, individual
condition, and environmental signals (Landys et al. 2006;
Cornelius et al. 2013).
Previous research examining the relationship between
plasma TRIG and mass gain has found that elevated
TRIG positively indicates an individual’s body mass gain
(“physiological fattening rate”: Jenni and Schwilch 2001;
Cerasale and Guglielmo 2006; Anteau and Afton 2008;
but see Dietz et al. 2009). We therefore predicted that if
individual changes in body mass occurred in direct
response to exogenous baseline CORT elevation, we
would have also detected a corresponding increase in
plasma TRIG. Interestingly, we detected no difference in
plasma TRIG secretion between our control and high
CORT groups on day 4 or day 7 postimplantation, nor
were there any apparent trends in the data. Similar non-
trends have been detected in red knots (Calidris canutus)
(Dietz et al. 2009) and western sandpipers (Calidris
mauri) (Seaman et al. 2005); however, in the latter case,
this may have been due to methodological differences
used to stimulate foraging and, therefore, changes in body
mass (Seaman et al. 2005). Although we did not fast indi-
viduals to stimulate body mass gain, this lack of a trend
may result from the time lag between foraging, digestion,
and circulating triglycerides, with the concentration of
plasma TRIG increasing throughout the day (Jenni and
Jenni-Eiermann 1996). Therefore, we may not have been
able to detect a difference in our birds as they were sam-
pled prior to feeding, exhibiting no relationship to treat-
ment group despite the increased signal of energetic
demand (i.e., elevated baseline CORT). Indeed, treatment
differences in fattening rates may have been more detecti-
ble postfeeding in the early afternoon or evident through
differences in foraging rates or amount of food con-
sumed. Future studies seeking to establish causal links
between baseline GCs, fattening rates and changes in body
mass should ideally account for changes in foraging
behavior if possible.
Acknowledgments
We thank the staff and volunteers at the PWRC for logis-
tical support, particularly L. Bonczek, S. Crowell, K.M.
McBride, G. Olsen, R. Therrien, and S. Yanuzzi. We
thank T. Baker for assistance in data collection and two
anonymous reviewers for their feedback on this manu-
script. Any use of trade, product, or firm names is for
descriptive purposes only and does not imply endorse-
ment by the U.S. Government. This research was sup-
ported by the Natural Sciences Engineering and Research
Council of Canada [Grant # 478021-2015] and the
Canada Research Chairs Program.
Conflict of Interest
None declared.
References
Almasi, B., A. Roulin, S. Jenni-Eiermann, and L. Jenni. 2008.
Parental investment and its sensitivity to corticosterone is
linked to melanin-based coloration in barn owls. Horm.
Behav. 58:217–223.
Angelier, F., C. Clement-Chastel, G. W. Gabrielsen, and O.
Chastel. 2007. Corticosterone and time-activity budget: an
experiment with black-legged kittiwakes. Horm. Behav.
52:482–491.
Angelier, F., C. Clement-Chastel, J. Welcker, G. W. Gabrielsen,
and O. Chastel. 2009. How does corticosterone affect
parental behaviour and reproductive success? A study of
prolactin in black-legged kittiwakes. Funct. Ecol. 23:784–
793.
Angelier, F., J. C. Wingfield, H. Weimerskirch, and O. Chastel.
2010. Hormonal correlates of individual quality in a long-
lived bird: a test of the “corticosterone-fitness hypothesis”.
Biol. Lett. 6:846–849.
Anteau, M. J., and A. D. Afton. 2008. Using plasma-lipid
metabolites to index changes in lipid reserves of free-living
lesser scaup (Aythya affinis). Auk 125:354–357.
Astheimer, L. B., W. A. Butterner, and J. C. Wingfield. 1992.
Interactions of corticosterone with feeding, activity and
metabolism in passerine birds. Ornis Scandinavica
23:355–365.
Be^ty, J., G. Gauthier, and J.-F. Giroux. 2003. Body condition,
migration, and the timing of reproduction in snow geese: a
test of the condition-dependent model of optimal clutch
size. Am. Nat. 162:110–121.
Bonier, F., P. R. Martin, and J. C. Wingfield. 2007. Maternal
corticosteroids influence primary offspring sex ratio in a
free-ranging passerine bird. Behav. Ecol. 8:1045–1050.
Bourgeon, S., and T. Raclot. 2006. Corticosterone selectively
decreases humoral immunity in female eiders during
incubation. J. Exp. Biol. 209:4957–4965.
Breuner, C. W., and T. P. Hahn. 2003. Integrating stress
physiology, environmental change, and behavior in free-
living sparrows. Horm. Behav. 43:115–123.
Breuner, C. W., A. L. Greenberg, and J. C. Wingfield.
1998. Non-invasive corticosterone treatment rapidly
increases activity in Gambel’s white-crowned sparrows
(Zonotrichia leucophrys gambelii). Gen. Comp. Endocrinol.
111:386–394.
Cerasale, D. J., and C. G. Guglielmo. 2006. Dietary effects on
prediction of body mass changes in birds by plasma
metabolites. Auk 123:836–846.
ª 2016 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd. 1709
H. L. Hennin et al. Glucocorticoids Drive Body Mass
Cornelius, J. M., T. Boswell, S. Jenni-Eiermann, C. W.
Breuner, and M. Ramenofsky. 2013. Contributions of
endocrinology to the migration life history of birds. Gen.
Comp. Endocrinol. 190:47–60.
Crespi, E. J., T. D. Williams, T. S. Jessop, and B. Delehanty.
2013. Life history and the ecology of stress: how do
glucocorticoid hormones influence life-history variation in
animals? Funct. Ecol. 27:93–106.
Criscuolo, F., O. Chastel, F. Bertile, G. W. Gabrielsen, Y. Le
Maho, and T. Raclot. 2005. Corticosterone alone does not
trigger a short term behavioural shift in incubating female
common eiders Somateria mollissima, but does modify long
term reproductive success. J. Avian Biol. 36:306–312.
Crossin, G. T., P. N. Trathan, R. A. Phillips, K. B. Gorman, A.
Dawson, K. Q. Sakamoto, et al. 2012. Corticosterone
predicts foraging behavior and parental care in macaroni
penguins. Am. Nat. 180:E31–E41.
Crossin, G. T., O. P. Love, S. J. Cooke, and T. D. Williams.
2015. Glucocorticoid manipulation in free-living animals:
considerations of dose delivery, life-history context and
reproductive state. Funct. Ecol. 30:116–125.
Dallman, M. F., A. M. Strack, S. F. Akana, M. J. Bradbury, E.
S. Hanson, K. A. Scribner, et al. 1993. Feast or famine:
critical role of glucocorticoids with insulin in daily energy
flow. Front. Neuroendocrinol. 14:303–347.
Descamps, S., J. Be^ty, O. P. Love, and H. G. Gilchrist. 2011.
Individual optimization of reproduction in a long-lived
migratory bird: a test of the condition-dependent model of
laying date and clutch size. Funct. Ecol. 25:671–681.
Dietz, M. W., S. Jenni-Eiermann, and T. Piersma. 2009. The
use of plasma metabolites to predict weekly body-mass
change in red knots. Condor 111:88–99.
Faure, J. M., G. Val-Laillet, G. Guy, M.-D. Bernade, and D.
Guememe. 2003. Fear and stress reactions in two species of
duck and their hybrid. Horm. Behav. 43:568–572.
Gladbach, A., D. J. Gladbach, and P. Quillfeldt. 2010. Seasonal
clutch size decline and individual variation in the timing of
breed are related to female body condition in a non-
migratory species, the Upland Goose Chloephaga picta
leucoptera. J. Ornithol. 151:817–825.
Goutte, A., C. Clement-Chastel, B. Moe, C. Bech, G. W.
Gabrielsen, and O. Chastel. 2011. Experimentally reduced
corticosterone release promotes early breeding in black-
legged kittiwakes. J. Exp. Biol. 214:2005–2013.
Hennin, H. L., P. Legagneaux, J. Be^ty, T. D. Williams, H. G.
Gilchrist, T. M. Baker, et al. 2015. Pre-breeding energetic
management in a mixed-strategy breeder. Oecologia
177:235–243.
Holberton, R. L. 1999. Changes in patterns of corticosterone
secretion concurrent with migratory fattening in a
neotropical migratory bird. Gen. Comp. Endocrinol. 116:49–
58.
Holberton, R. L., C. M. Wilson, M. J. Hunter, W. B. Cash,
and C. G. Sims. 2007. The role of corticosterone in
suppressing migratory lipogenesis in the dark-eyed junco,
Junco hyemalis: a model for central and peripheral
regulation. Physiol. Biochem. Zool. 80:125–137.
Jenni, L., and S. Jenni-Eiermann. 1996. Metabolic responses to
diurnal feeding patterns during the postbreeding, moulting
and migratory periods in passerine birds. Funct. Ecol.
10:73–80.
Jenni, L., and R. Schwilch. 2001. Plasma metabolite levels
indicate change in body mass in reed warblers Acrocephalus
scirpaceus. Avian Sci. 1:55–65.
Jenni-Eiermann, S., E. Glaus, M. Gr€uebler, H. Schwabl, and L.
Jenni. 2008. Glucocorticoid response to food availability in
breeding barn swallows (Hirundo rustica). Gen. Comp.
Endocrinol. 155:558–565.
Kisdi, E., G. Meszena, and L. Pasztor. 1998. Individual
optimization: mechanisms shaping the optimal reaction
norm. Evol. Ecol. 12:211–221.
Kitaysky, A. S., J. C. Wingfield, and J. F. Piatt. 1999. Dynamics
of food availability, body condition and physiological stress
response in breeding black-legged kittiwakes. Funct. Ecol.
14:577–584.
Kitaysky, A. S., J. F. Piatt, and J. C. Wingfield. 2007. Stress
hormones link food availability and population processes in
seabirds. Mar. Ecol. Prog. Ser. 352:245–258.
Landys, M. M., M. Ramenofsky, and J. C. Wingfield. 2006.
Actions of glucocorticoids at a seasonal baseline as compared
to stress-related levels in the regulation of periodic life
processes. Gen. Comp. Endocrinol. 148:132–149.
Lepage, D., G. Gauthier, and S. Menu. 2000. Reproductive
consequences of egg-laying decisions in snow geese. J. Anim.
Ecol. 69:414–427.
L~ohmus, M., L. F. Sundstr€om, and F. R. Moore. 2006. Non-
invasive corticosterone treatment changes foraging intensity
in red-eyed vireos Vireo olivaceus. J. Avian Biol. 37:523–526.
Love, O. P., E. H. Chin, K. E. Wynne-Edwards, and T. D.
Williams. 2005. Stress hormones: a link between maternal
condition and sex-biased reproductive investment. Am. Nat.
166:751–766.
McNamara, J. M., and A. I. Houston. 1996. State-dependent
life histories. Nature 380:215–221.
McNamara, J. M., and A. I. Houston. 2008. Optimal annual
routines: behaviour in the context of physiology and
ecology. Philos. Trans. R. Soc. B 363:301–319.
M€uller, C., B. Almasi, A. Roulin, C. W. Breuner, S. Jenni-
Eiermann, and L. Jenni. 2009a. Effects of corticosterone
pellets on baseline and stress-induced corticosterone and
corticosteroid-binding-globulin. Gen. Comp. Endocrinol.
160:59–66.
M€uller, C., S. Jenni-Eiermann, and L. Jenni. 2009b. Effects of a
short period of elevated circulating corticosterone on
postnatal growth in free-living Eurasian kestrels Falco
tinnunculus. J. Exp. Biol. 212:1406–1412.
Nagy, K. A. 2005. Field metabolic rate and body size. J. Exp.
Biol. 208:1621–1625.
1710 ª 2016 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd.
Glucocorticoids Drive Body Mass H. L. Hennin et al.
Nilsson, P. B., T. E. Hollmen, S. Atkinson, K. L. Mashburn, P.
A. Tuomi, D. Esler, et al. 2008. Effects of ACTH, capture,
and short term confinement on glucocorticoid
concentrations in harlequin ducks (Histrionicus histrionicus).
Comp. Biochem. Physiol. A 149:275–283.
Noirault, J., D. Guememe, G. Guy, and J. M. Faure. 1999.
Corticosterone plasma concentration in male mule ducks:
effects of sampling sites, repeated samplings and ACTH
injections. Br. Poult. Sci. 40:304–308.
Palm, E. C., D. Esler, E. M. Anderson, T. D. Williams, O. P.
Love, and M. T. Wilson. 2013. Baseline corticosterone in
wintering marine birds: methodological considerations and
ecological patterns. Physiol. Biochem. Zool. 86:346–353.
Romero, L. M. 2002. Seasonal changes in plasma
glucocorticoid concentrations in free-living vertebrates. Gen.
Comp. Endocrinol. 128:1–24.
Romero, L. M., and J. M. Reed. 2002. Collecting baseline
corticosterone samples in the field: is under 3 min good
enough? Comp. Biochem. Physiol. A 140:73–79.
Rowe, L., D. Ludwig, and D. Schluter. 1994. Time, condition,
and the seasonal decline of avian clutch size. Am. Nat.
143:698–722.
Seaman, D. A., C. G. Guglielmo, and T. D. Williams. 2005.
Effects of physiological state, mass change and diet on
plasma metabolite profiles in the western sandpiper Caladris
mauri. J. Exp. Biol. 208:761–769.
Stearns, S. C. 1992. The evolution of life histories. Oxford
Univ. Press, Oxford.
Williams, T. D., N. Warnock, J. Y. Takekawa, and M. A.
Bishop. 2007. Flyway-scale variation in plasma triglyceride
levels as an index of refuelling rate in spring-migrating
western sandpipers (Calidris mauri). Auk 124:886–897.
Wingfield, J. C., D. L. Maney, C. W. Breuner, J. D. Jacobs, S.
Lynn, M. Ramenofsky, et al. 1998. Ecological bases of
hormone-behavior interactions: the “emergency life history
stage”. Am. Zool. 38:191–206.
Zajac, R. M., D. J. Cerasale, and C. G. Guglielmo. 2006. The
rapid response of plasma metabolites to changes in feeding
rate in a small passerine Wilsonia pusilla. J. Avian Biol.
37:405–408.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Table S1. Summary of sample sizes collected for corticos-
terone and mass-corrected triglycerides (fattening rate).
ª 2016 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd. 1711
H. L. Hennin et al. Glucocorticoids Drive Body Mass
